Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) has completed its acquisition of Proteolix, Inc., a privately held biopharmaceutical company focused on discovering ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE